| |
| |
|
| Insider
Information: |
Weiss Michael S |
| Relationship: |
Director |
| City: |
Berkeley Heights |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
16,329,233 |
|
|
Indirect Shares
|
14,546,388 |
|
|
| Direct
Value |
$207,679,882 |
|
|
|
Indirect Value
|
$228,994,301 |
|
|
| Total
Shares |
30,875,621 |
|
|
| Total
Value |
$436,674,183 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
2
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
 -2.8%
|
-135.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keryx Biopharmaceuticals Inc |
KERX |
10% Owner |
2010-05-10 |
1,320,418 |
2003-11-21 |
0 |
Premium* |
|
|
Genta Inc De |
GNTAQ |
Director |
2005-08-05 |
537,238 |
2004-07-14 |
0 |
Premium* |
|
|
XTL Biopharmaceuticals Ltd |
XTLBY |
Director |
2008-08-22 |
25,000 |
|
0 |
Premium* |
|
|
TG Therapeutics Inc |
TGTX |
CEO |
2024-01-06 |
13,074,929 |
2020-06-22 |
14,434,214 |
Premium* |
|
|
Fortress Biotech, Inc. |
FBIO |
See Remarks, Director,... |
2024-01-01 |
1,346,985 |
2013-12-19 |
0 |
Premium* |
|
|
Checkpoint Therapeutics, Inc. |
CKPT |
Director |
2017-06-15 |
0 |
2024-05-14 |
112,174 |
Premium* |
|
|
Avenue Therapeutics, Inc. |
ATXI |
Director |
2018-08-07 |
24,663 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TGTX |
TG Therapeutics Inc |
CEO and President |
• • – |
2022-01-04 |
4 |
S |
$19.20 |
$720,941 |
D/D |
(37,549) |
13,455,697 |
0 |
% |
|
| TGTX |
TG Therapeutics Inc |
CEO and President |
• • – |
2022-01-05 |
4 |
S |
$18.31 |
$561,586 |
D/D |
(30,671) |
10,988,021 |
0 |
% |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-03-21 |
4 |
AS |
$18.25 |
$1,462,376 |
D/D |
(80,000) |
15,000 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chariman and CEO |
• • – |
2006-04-18 |
4 |
AS |
$17.03 |
$683,472 |
D/D |
(40,000) |
15,000 |
|
- |
|
| TGTX |
TG Therapeutics Inc |
See Remarks |
• • • |
2014-12-16 |
4 |
S |
$16.44 |
$3,462,560 |
D/D |
(210,618) |
8,120,773 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-02-21 |
4 |
AS |
$16.31 |
$665,934 |
D/D |
(40,000) |
15,000 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-05-16 |
4 |
AS |
$15.45 |
$390,087 |
D/D |
(25,000) |
30,000 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-05-17 |
4 |
AS |
$14.72 |
$222,846 |
D/D |
(15,000) |
15,000 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-12-11 |
4 |
AS |
$14.53 |
$64,101 |
D/D |
(4,395) |
33,500 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-12-07 |
4 |
AS |
$14.49 |
$779,556 |
D/D |
(53,435) |
15,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-12-08 |
4 |
AS |
$14.49 |
$395,476 |
D/D |
(27,102) |
15,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-12-11 |
4 |
AS |
$14.40 |
$267,640 |
D/D |
(18,500) |
15,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-12-12 |
4 |
AS |
$14.40 |
$216,306 |
D/D |
(15,000) |
15,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-12-13 |
4 |
AS |
$14.30 |
$306,176 |
D/D |
(21,337) |
15,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-12-14 |
4 |
AS |
$14.14 |
$325,088 |
D/D |
(22,887) |
15,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-12-15 |
4 |
AS |
$14.09 |
$360,530 |
D/D |
(25,433) |
15,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-12-18 |
4 |
AS |
$13.70 |
$163,341 |
D/D |
(11,911) |
15,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-06-20 |
4 |
AS |
$12.41 |
$504,547 |
D/D |
(40,000) |
15,000 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-07-18 |
4 |
AS |
$11.41 |
$116,098 |
D/D |
(10,000) |
15,000 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
• – – |
2004-06-15 |
4 |
B |
$10.92 |
$54,600 |
D/D |
5,000 |
647,385 |
2.74 |
- |
|
| TGTX |
TG Therapeutics Inc |
CEO and President |
• • – |
2023-08-11 |
4 |
B |
$10.13 |
$1,013,000 |
D/D |
100,000 |
12,073,021 |
2.81 |
% |
|
| TGTX |
TG Therapeutics Inc |
CEO and President |
• • – |
2019-06-26 |
4 |
B |
$7.04 |
$351,750 |
I/I |
50,000 |
12,878,185 |
0.01 |
- |
|
| TGTX |
TG Therapeutics Inc |
See Remarks |
• • • |
2012-05-16 |
4 |
B |
$6.25 |
$9,375 |
D/D |
1,500 |
5,192,728 |
3.15 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
10% Owner |
– – • |
2010-05-03 |
4 |
S |
$6.16 |
$924,000 |
D/D |
(150,000) |
1,465,137 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
10% Owner |
– – • |
2010-05-09 |
4 |
S |
$6.09 |
$304,500 |
D/D |
(50,000) |
1,368,137 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
